The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Open accessAbstract
An international group of cancer geneticists review the level of evidence for the association of gene variants with the risk of breast cancer. It is difficult to draw firm conclusions from the data...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citationLiaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., Bose, S., Call, K. M., Tsou, H. C., Peacoke, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-64 · Cited by 2,091
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Saam, J., Arnell, C., Theisen, A., Moyes, K., Marino, I., Roundy, K. M., & Wenstrup, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,526
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496
Precision Medicine — Personalized, Problematic, and Promising
Jameson, J. L., & Longo, D. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsb1503104 · Cited by 1,106
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
The Breast and Ovarian Cancer Susceptibility Collaboration, Michailidou, K., Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), kConFab Investigators, Australian Ovarian Cancer Study Group, The GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network, Hall, P., Gonzalez-Neira, A., Ghoussaini, M., Dennis, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2563 · Cited by 1,069
Self-citationPALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
The Breast Cancer Susceptibility Collaboration (UK), Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., et al. (2007) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,003
Self-citationCancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D. G., Izatt, L., Eeles, R. A., Adlard, J., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt095 · Cited by 951
Self-citationPlon, S. E., Eccles, D. M., Easton, D., Foulkes, W. D., Genuardi, M., Greenblatt, M. S., Hogervorst, F. B. L., Hoogerbrugge, N., Spurdle, A. B., Tavtigian, S. V., et al. (2008) · Human Mutation · doi:10.1002/humu.20880 · Cited by 912
Self-citationLifetime Cancer Risks in Individuals with Germline PTEN Mutations
Tan, M.-H., Mester, J. L., Ngeow, J., Rybicki, L. A., Orloff, M. S., & Eng, C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2283 · Cited by 892
Frequency and Spectrum of Cancers in the Peutz-Jeghers Syndrome
Hearle, N., Schumacher, V., Menko, F. H., Olschwang, S., Boardman, L. A., Gille, J. J. P., Keller, J. J., Westerman, A. M., Scott, R. J., Lim, W., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0083 · Cited by 855
Breast-Cancer Risk in Families with Mutations in PALB2
Antoniou, A. C., Casadei, S., Heikkinen, T., Barrowdale, D., Pylkäs, K., Roberts, J., Lee, A., Subramanian, D., De Leeneer, K., Fostira, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400382 · Cited by 851
Self-citationATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles
The Breast Cancer Susceptibility Collaboration (UK), Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., et al. (2006) · Nature Genetics · doi:10.1038/ng1837 · Cited by 743
Self-citationPharoah, P. D. P., Guilford, P., & Caldas, C. (2001) · Gastroenterology · doi:10.1053/gast.2001.29611 · Cited by 638
Self-citationMultiple Primary Cancers in Families With Li-Fraumeni Syndrome
Hisada, M., Garber, J. E., Li, F. P., Fung, C. Y., & Fraumeni, J. F. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.606 · Cited by 557
Cancer Risks and Mortality in Heterozygous ATM Mutation Carriers
Thompson, D., Duedal, S., Kirner, J., McGuffog, L., Last, J., Reiman, A., Byrd, P., Taylor, M., & Easton, D. F. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji141 · Cited by 543
Self-citationGermline mutations in RAD51D confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (UK), Loveday, C., Turnbull, C., Ramsay, E., Hughes, D., Ruark, E., Frankum, J. R., Bowden, G., Kalmyrzaev, B., Warren-Perry, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.893 · Cited by 534
Self-citationVariation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Self-citation(2004) · The American Journal of Human Genetics · doi:10.1086/421251 · Cited by 471
A recurrent mutation in PALB2 in Finnish cancer families
Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A., Pylkäs, K., Karppinen, S.-M., Rapakko, K., et al. (2007) · Nature · doi:10.1038/nature05609 · Cited by 466
Easton, D. F., Deffenbaugh, A. M., Pruss, D., Frye, C., Wenstrup, R. J., Allen-Brady, K., Tavtigian, S. V., Monteiro, A. N. A., Iversen, E. S., Couch, F. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521032 · Cited by 455
Self-citationMutations in BRIP1 confer high risk of ovarian cancer
Rafnar, T., Gudbjartsson, D. F., Sulem, P., Jonasdottir, A., Sigurdsson, A., Jonasdottir, A., Besenbacher, S., Lundin, P., Stacey, S. N., Gudmundsson, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.955 · Cited by 406
Goldgar, D. E., Easton, D. F., Deffenbaugh, A. M., Monteiro, A. N. A., Tavtigian, S. V., & Couch, F. J. (2004) · The American Journal of Human Genetics · doi:10.1086/424388 · Cited by 391
Self-citationHigh cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome
Bubien, V., Bonnet, F., Brouste, V., Hoppe, S., Barouk-Simonet, E., David, A., Edery, P., Bottani, A., Layet, V., Caron, O., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101339 · Cited by 376
Hogervorst, F. B. L., Nederlof, P. M., Gille, J. J. P., McElgunn, C. J., Grippeling, M., Pruntel, R., Regnerus, R., van Welsem, T., van Spaendonk, R., Menko, F. H., et al. (2003) · PubMed · Cited by 314
Antoniou, A. C., Spurdle, A. B., Sinilnikova, O. M., Healey, S., Pooley, K. A., Schmutzler, R. K., Versmold, B., Engel, C., Meindl, A., Arnold, N., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.02.008 · Cited by 283
Self-citationGermline RAD51C mutations confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (BCSC) (UK), Loveday, C., Turnbull, C., Ruark, E., Xicola, R. M. M., Ramsay, E., Hughes, D., Warren-Perry, M., Snape, K., Eccles, D., et al. (2012) · Nature Genetics · doi:10.1038/ng.2224 · Cited by 252
Self-citationMosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer
The Breast and Ovarian Cancer Susceptibility Collaboration, Ruark, E., Wellcome Trust Case Control Consortium, Snape, K., Humburg, P., Loveday, C., Bajrami, I., Brough, R., Rodrigues, D. N., Renwick, A., et al. (2013) · Nature · doi:10.1038/nature11725 · Cited by 248
Self-citationLindor, N. M., Guidugli, L., Wang, X., Vallée, M. P., Monteiro, A. N. A., Tavtigian, S., Goldgar, D. E., & Couch, F. J. (2012) · Human Mutation · doi:10.1002/humu.21627 · Cited by 235
Self-citationGermline p53 Mutations in a Cohort with Childhood Sarcoma: Sex Differences in Cancer Risk
Hwang, S.-J., Lozano, G., Amos, C. I., & Strong, L. C. (2003) · The American Journal of Human Genetics · doi:10.1086/374567 · Cited by 229
Rare variants in the ATMgene and risk of breast cancer
Goldgar, D. E., Healey, S., Dowty, J. G., Da Silva, L., Chen, X., Spurdle, A. B., Terry, M. B., Daly, M. J., Buys, S. M., Southey, M. C., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2919 · Cited by 226
Self-citationCurses—Winner's and Otherwise—in Genetic Epidemiology
Kraft, P. (2008) · Epidemiology · doi:10.1097/ede.0b013e318181b865 · Cited by 225
Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Systematic Review and Meta-Analysis
Friebel, T. M., Domchek, S. M., & Rebbeck, T. R. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju091 · Cited by 225
Self-citationThe Consortium of Investigators of Modifiers of BRCA1/2, Lee, A. J., The Breast Cancer Association Consortium, Cunningham, A. P., Kuchenbaecker, K. B., Mavaddat, N., Easton, D. F., & Antoniou, A. C. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.730 · Cited by 214
Self-citationThompson, E. R., Doyle, M. A., Ryland, G. L., Rowley, S. M., Choong, D. Y. H., Tothill, R. W., Thorne, H., kConFab, Barnes, D. R., Li, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002894 · Cited by 211
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic instability
Heikkinen, K. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi360 · Cited by 208
Germline RECQL mutations are associated with breast cancer susceptibility
Cybulski, C., Carrot-Zhang, J., Kluźniak, W., Rivera, B., Kashyap, A., Wokołorczyk, D., Giroux, S., Nadaf, J., Hamel, N., Zhang, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3284 · Cited by 189
Self-citationExome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer
Kiiski, J. I., Pelttari, L. M., Khan, S., Freysteinsdottir, E. S., Reynisdottir, I., Hart, S. N., Shimelis, H., Vilske, S., Kallioniemi, A., Schleutker, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407909111 · Cited by 187
Self-citationRare Mutations in XRCC2 Increase the Risk of Breast Cancer
Park, D. J., Lesueur, F., Nguyen-Dumont, T., Pertesi, M., Odefrey, F., Hammet, F., Neuhausen, S. L., John, E. M., Andrulis, I. L., Terry, M. B., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.027 · Cited by 185
Self-citationWeischer, M., Nordestgaard, B. G., Pharoah, P., Bolla, M. K., Nevanlinna, H., van't Veer, L. J., Garcia-Closas, M., Hopper, J. L., Hall, P., Andrulis, I. L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7336 · Cited by 181
Self-citationNickels, S., Truong, T., Hein, R., Stevens, K., Buck, K., Behrens, S., Eilber, U., Schmidt, M., Häberle, L., Vrieling, A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003284 · Cited by 163
Self-citationCHEK2 variant I157T may be associated with increased breast cancer risk
Kilpivaara, O., Vahteristo, P., Falck, J., Syrjäkoski, K., Eerola, H., Easton, D., Bartkova, J., Lukas, J., Heikkilä, P., Aittomäki, K., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20299 · Cited by 163
Self-citationBartkova, J., Tommiska, J., Oplustilova, L., Aaltonen, K., Tamminen, A., Heikkinen, T., Mistrik, M., Aittomäki, K., Blomqvist, C., Heikkilä, P., et al. (2008) · Molecular Oncology · doi:10.1016/j.molonc.2008.09.007 · Cited by 158
Heikkinen, T., Kärkkäinen, H., Aaltonen, K., Milne, R. L., Heikkilä, P., Aittomäki, K., BLOMQVIST, C. P., & Nevanlinna, H. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3128 · Cited by 158
Campa, D., Kaaks, R., Marchand, L. L., Haiman, C. A., Travis, R. C., Berg, C. D., Buring, J. E., Chanock, S. J., Diver, W. R., Dostal, L., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr265 · Cited by 157
Risk of breast cancer in Lynch syndrome: a systematic review
Win, A. K., Lindor, N. M., & Jenkins, M. A. (2013) · Breast Cancer Research · doi:10.1186/bcr3405 · Cited by 148
RAD51C is a susceptibility gene for ovarian cancer
Pelttari, L. M., Heikkinen, T., Thompson, D. J., Kallioniemi, A. H., Schleutker, J., Holli, K., BLOMQVIST, C. P., Aittomäki, K., Bützow, R. C., & Nevanlinna, H. A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr229 · Cited by 142
Damiola, F., Pertesi, M., Oliver, J., Calvez‐Kelm, F. L., Voegele, C., Young, E. L., Robinot, N. R., Forey, N., Durand, G., Vallée, M., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3669 · Cited by 133
Self-citationHayes, D. F., Allen, J. D., Compton, C. C., Gustavsen, G. G., Leonard, D. G. B., Mccormack, R. T., Newcomer, L. N., Pothier, K. C., Ransohoff, D. F., Schilsky, R. L., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005950 · Cited by 124
Discovering moderate-risk breast cancer susceptibility genes
Hollestelle, A., Wasielewski, M., Martens, J. W. M., & Schutte, M. E. M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.02.009 · Cited by 111
Janin, N., Andrieu, N., Ossian, K., Laugé, A., Croquette, M.-F., Griscelli, C., Debré, M., Paillerets, B. B., Aurias, A., & Stoppa‐Lyonnet, D. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690460 · Cited by 109
Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer
Sun, J., Wang, Y., Xia, Y., Xu, Y., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005228 · Cited by 104
Calvez‐Kelm, F. L., Lesueur, F., Damiola, F., Vallée, M., Voegele, C., Babikyan, D., Durand, G., Forey, N., McKay‐Chopin, S., Robinot, N. R., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2810 · Cited by 89
Self-citationJohnson, N., Fletcher, O., Naceur‐Lombardelli, C., dos‐Santos‐Silva, I., Ashworth, A., & Peto, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67627-1 · Cited by 85
Age-specific risk of breast cancer in women with neurofibromatosis type 1
Seminog, O. O., & Goldacre, M. J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.78 · Cited by 84
The FDA and Genomic Tests — Getting Regulation Right
Evans, B. J., Burke, W., & Jarvik, G. P. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1501194 · Cited by 81
Zhang, G., Zeng, Y., Liu, Z., & Wei, W. (2013) · Tumor Biology · doi:10.1007/s13277-013-0830-z · Cited by 70
Evaluation of RAD50 in familial breast cancer predisposition
Tommiska, J., Seal, S., Renwick, A., Barfoot, R., Baskcomb, L., Jayatilake, H., Bártková, J., Tallila, J., Kaare, M., Tamminen, A., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21738 · Cited by 68
Self-citationCutting the Gordian Helix — Regulating Genomic Testing in the Era of Precision Medicine
Lander, E. S. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1501964 · Cited by 55
MUTYH gene variants and breast cancer in a Dutch case–control study
Out, A. A., Wasielewski, M., Huijts, P. E. A., van Minderhout, I. J. H. M., Houwing‐Duistermaat, J. J., Tops, C. M. J., Nielsen, M., Seynaeve, C., Wijnen, J., Breuning, M. H., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1965-0 · Cited by 52
Self-citationBreast Cancer Risks for BRCA1/2 Carriers
Easton, D. F., Hopper, J. L., Thomas, D. C., Antoniou, A. C., Pharoah, P. D. P., Whittemore, A. S., & Haile, R. W. (2004) · Science · doi:10.1126/science.306.5705.2187c · Cited by 51
Self-citationPelttari, L. M., Kiiski, J. I., Nurminen, R., Kallioniemi, A. H., Schleutker, J., Gylfe, A. E., Aaltonen, L. A., Leminen, A., Heikkilä, P., BLOMQVIST, C. P., et al. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-100852 · Cited by 49
Rudolph, A., Milne, R. L., Truong, T., Knight, J. A., Seibold, P., Flesch‐Janys, D., Behrens, S., Eilber, U., Bolla, M. K., Wang, Q., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29188 · Cited by 47
Self-citationFDA Regulation of Laboratory-Developed Diagnostic Tests
Sharfstein, J. M. (2015) · JAMA · doi:10.1001/jama.2014.18135 · Cited by 36
Growing Recognition of the Role for Rare Missense Substitutions in Breast Cancer Susceptibility
Tavtigian, S. V., & Chenevix‐Trench, G. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.13.143 · Cited by 30
Self-citationHe, M. Y., Di, G., Cao, A., Hu, Z., Jin, W., Shen, Z., & Shao, Z. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1700-2 · Cited by 22
RAD50 gene mutations are not likely a risk factor for breast cancer in Poland
Mosor, M., Ziółkowska‐Suchanek, I., Rożnowski, K., Baranowska, M., Januszkiewicz‐Lewandowska, D., & Nowak, J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0992-y · Cited by 13
Cited by
The personal and clinical utility of polygenic risk scores
Torkamani, A., Wineinger, N. E., & Topol, E. J. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0018-x · Cited by 1,623
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496
Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
Breast Cancer Association Consortium (2021) · New England Journal of Medicine · doi:10.1056/nejmoa1913948 · Cited by 1,136
Precision Medicine — Personalized, Problematic, and Promising
Jameson, J. L., & Longo, D. L. (2015) · New England Journal of Medicine · doi:10.1056/nejmsb1503104 · Cited by 1,106
Key steps for effective breast cancer prevention
Britt, K. L., Cuzick, J., & Phillips, K.-A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0266-x · Cited by 992
Metadata
- Authors
- Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., Devilee, P., Meindl, A., Couch, F. J., Southey, M., Goldgar, D. E., Evans, D. G. R., Chenevix-Trench, G., Rahman, N., Robson, M., Domchek, S. M., & Foulkes, W. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-06-04
- Volume
- 372
- Issue
- 23
- Pages
- 2243-2257
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1871202334
- Cited by
- 920
- References
- 71
- FWCI
- 67.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.